fig4

Figure 4. Articles focused on locoregional treatments and systemic therapies. AFP: Alpha-fetoprotein; AFP-L3: Lens culinaris agglutinin-reactive fraction of AFP; DCP: des-gamma-carboxy prothrombin; PIVKA-II: protein induced by vitamin K absence or antagonist-II; RFA: radiofrequency ablation; TACE: transarterial chemoembolization; OS: overall survival; PFS: progression-free survival; NLR: neutrophil-to-lymphocyte ratio; GPS: Glasgow Prognostic Score; neo-GPS: neo-Glasgow Prognostic Score; PET: positron emission tomography; SUV: standardized uptake value; 18F-FDG: fluorine-18 fluorodeoxyglucose; 11C-acetate: carbon-11 acetate; CT: computed tomography; TSUV: tumor standardized uptake value; IAUV: intrahepatic arterial uptake value; PD-1: programmed cell death protein 1; TKI: tyrosine kinase inhibitor; HCC: hepatocellular carcinoma.